There is a great deal of information that can be gained by examining a patient’s genetics. For example, genetic testing can assess a patient’s hereditary risk of Alzheimer’s disease. Genetic testing can also determine which medications are likely to be effective or ineffective for treatment.
Genetic Testing and Cancer
Genetic testing can be used in a number of different ways to improve a patient’s health outcomes.
Know your carrier risk for inherited conditions
- Cancer Carrier Screening
- Alzheimer’s Disease
- Inherited Cardiomyopathy
- Pharmacogenetics
- DiabetesPredictTM
Cancer Carrier Screening
Specific genetic variants are associated with an increased risk of developing certain cancers.
Testing for genetic variants provides information to determine the most effective and efficient treatment plans. Contact the laboratory for the most up-to-date listing of available cancer screening targets.
test
CCS
sample type
Blood/Buccal Swab
Stability
5 Days
Temperature
Refrigerated
TURNAROUND TIME
2-3 Weeks
Alzheimer’s Disease
The Alzheimer’s test examines multiple genes known to be associated with an increased risk of Alzheimer’s disease and genetic disorders that cause dementia.
Both early and late onset Alzheimer’s have a genetic component. Genetic testing can provide results to best determine treatment, psychosocial counseling and support programs.
test
ALZ
sample type
Blood/Buccal Swab
Stability
5 Days
Temperature
Refrigerated
TURNAROUND TIME
2-3 Weeks
Inherited Cardiomyopathy
The cardiomyopathy test examines an extensive list of genes associated with hereditary cardiomyopathies.
This test can benefit patients with personal or family history that is suggestive of hereditary cardiomyopathy and patients with symptoms of cardiomyopathy, a heart muscle disease that makes it more difficult to pump blood around the body. Results of this testing can help guide treatment plans.
test
ICM
sample type
Blood/Buccal Swab
Stability
5 Days
Temperature
Refrigerated
TURNAROUND TIME
2-3 Weeks
Pharmacogenetics
Our PGX testing helps reduce trial and error in the medication-assisted treatment of a wide variety of conditions.
Altered metabolic activity of one or more major CYP enzymatic pathways is highly prevalent and contributes to variable patient medication responses. Improve the efficacy of patient treatment plans using Luxor’s Pharmacogenetic testing results and reduce risks and costs associated with ineffective and/or potentially harmful medications.
test
PGX
sample type
Blood/Buccal Swab
Stability
5 Days
Temperature
Refrigerated
TURNAROUND TIME
1-2 Weeks
DiabetesPredictTM
DiabetesPredictTM is a genotyping tool that analyzes specific genetic markers that have been discovered to be associated with type II diabetes.
Knowledge about one’s predisposition to type II diabetes can allow for early intervention or lifestyle change, and can assist in prevention or management of the increasingly common disease.
test
DBTP
sample type
Buccal Swab
Stability
5 Days
Temperature
Refrigerated
TURNAROUND TIME
1-2 Weeks
